NCT04125212

Brief Summary

To investigate the effects of air pollution on surrogate cardio-metabolic outcomes in young healthy adults.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 21, 2019

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 14, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 16, 2020

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

September 16, 2021

Status Verified

September 1, 2021

Enrollment Period

4 months

First QC Date

October 11, 2019

Last Update Submit

September 14, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood pressure

    Systolic blood pressure and diastolic blood pressure

    Four months

Secondary Outcomes (1)

  • Systemic inflammatory

    Four months

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

non-smoker young healthy adults

You may qualify if:

  • Living in Peking University Health Science Center neighborhood.
  • Non smoker and no diseases.

You may not qualify if:

  • Advanced microvascular complications and active cardiovascular disease.
  • Pregnancy or intent to get pregnant during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University ,School of Public Health

Beijing, Beijing Municipality, 100191, China

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Collection of blood and urine samples

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 11, 2019

First Posted

October 14, 2019

Study Start

September 21, 2019

Primary Completion

January 16, 2020

Study Completion

June 1, 2022

Last Updated

September 16, 2021

Record last verified: 2021-09

Locations